首页> 外文期刊>Viruses >Ferrets as a Novel Animal Model for Studying Human Respiratory Syncytial Virus Infections in Immunocompetent and Immunocompromised Hosts
【24h】

Ferrets as a Novel Animal Model for Studying Human Respiratory Syncytial Virus Infections in Immunocompetent and Immunocompromised Hosts

机译:雪貂作为一种新型的动物模型,用于研究免疫功能和免疫功能低下的宿主中的人类呼吸道合胞病毒感染

获取原文
       

摘要

Human respiratory syncytial virus (HRSV) is an important cause of severe respiratory tract disease in immunocompromised patients. Animal models are indispensable for evaluating novel intervention strategies in this complex patient population. To complement existing models in rodents and non-human primates, we have evaluated the potential benefits of an HRSV infection model in ferrets ( Mustela putorius furo ). Nine- to 12-month-old HRSV-seronegative immunocompetent or immunocompromised ferrets were infected with a low-passage wild-type strain of HRSV subgroup A (10 5 TCID 50 ) administered by intra-tracheal or intra-nasal inoculation. Immune suppression was achieved by bi-daily oral administration of tacrolimus, mycophenolate mofetil, and prednisolone. Throat and nose swabs were collected daily and animals were euthanized four, seven, or 21 days post-infection (DPI). Virus loads were determined by quantitative virus culture and qPCR. We observed efficient HRSV replication in both the upper and lower respiratory tract. In immunocompromised ferrets, virus loads reached higher levels and showed delayed clearance as compared to those in immunocompetent animals. Histopathological evaluation of animals euthanized 4 DPI demonstrated that the virus replicated in the respiratory epithelial cells of the trachea, bronchi, and bronchioles. These animal models can contribute to an assessment of the efficacy and safety of novel HRSV intervention strategies.
机译:人类呼吸道合胞病毒(HRSV)是免疫受损患者严重呼吸道疾病的重要原因。在这种复杂的患者群体中,动物模型对于评估新型干预策略必不可少。为了补充现有的啮齿动物和非人类灵长类动物模型,我们评估了HRSV感染模型在雪貂(鼬鼬(Mustela putorius furo))中的潜在优势。 9到12个月大的HRSV阴性的免疫能力强或免疫受损的雪貂感染了HRSV亚组A(10 5 TCID 50)的低通量野生型菌株,通过气管内或鼻内接种给予。通过他克莫司,霉酚酸酯和泼尼松龙的每日两次口服给药可实现免疫抑制。每天收集咽喉和鼻拭子,并在感染后四,七或二十天对动物实施安乐死。通过定量病毒培养和qPCR确定病毒载量。我们观察到HRSV在上呼吸道和下呼吸道均有效复制。与免疫功能正常的动物相比,免疫受损的雪貂的病毒载量达到较高水平,并且清除延迟。对4 DPI安乐死的动物的组织病理学评估表明,该病毒在气管,支气管和细支气管的呼吸道上皮细胞中复制。这些动物模型可有助于评估新型HRSV干预策略的功效和安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号